MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 168 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2020. The put-call ratio across all filers is 1.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,365,000 | +809.6% | 101,537 | +228.0% | 0.03% | +725.0% |
| Q1 2020 | $260,000 | +0.4% | 30,953 | +16.7% | 0.00% | +33.3% |
| Q4 2019 | $259,000 | +9.3% | 26,520 | +6.0% | 0.00% | 0.0% |
| Q3 2019 | $237,000 | -51.9% | 25,023 | -39.7% | 0.00% | -50.0% |
| Q2 2019 | $493,000 | – | 41,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |